Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
, including ‘omics, epigenetics, big data, computational biology, bioinformatics, and biomedical engineering. ABOUT COLLEGE OF HEALTH SCIENCES The College of Health Sciences (CHS) pioneers research in
-
cell targeting • Genome engineering, including CRISPR-based systems, targeted epigenetic editing, and chromatin architecture manipulation for immunotherapy Applicants working at the interface
-
Bioinformatician A/B Job Profile Title Bioinformatician A Job Description Summary The Human Pancreas Analysis Program (https://hpap.pmacs.upenn.edu/) and Faryabi Lab (https://faryabilab.com) seeking multiple
-
. The candidate will perform: 1) single cell whole transcriptome and TCR clonotype analysis using short- and long read next generation sequencing, 2) epigenetic profiling of immune cells to discern the temporal
-
interactions Plant responses to combined abiotic and biotic stress, including molecular and epigenetic adaptation mechanisms (‘priming’, resilience) Root physiology and rhizosphere processes Physiology of plants
-
savings options Employee and dependent educational benefits Life insurance coverage Employee discounts programs For detailed information on benefits and eligibility, please visit: http://uhr.rutgers.edu
-
savings options Employee and dependent educational benefits Life insurance coverage Employee discounts programs For detailed information on benefits and eligibility, please visit: http://uhr.rutgers.edu
-
superb faculty with strengths in cellular therapies, cancer genetics and epigenetics, tumor modeling, and experimental therapeutics. The Department of Pediatrics, HCI and Primary Children’s Hospital (PCH
-
the molecular mechanisms driving treatment resistance that include cell intrinsic (e.g. mutation, tumor heterogeneity, cell plasticity, epigenetic) and microenvironment events, with opportunities
-
fundamental and translational science. Potential projects include: (1) Defining expression and epigenetic heterogeneity in head and neck cancers in contexts such as metastasis, recurrence, or treatment failure